210 related articles for article (PubMed ID: 18752571)
1. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.
Balduini A; Pallotta I; Malara A; Lova P; Pecci A; Viarengo G; Balduini CL; Torti M
J Thromb Haemost; 2008 Nov; 6(11):1900-7. PubMed ID: 18752571
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome.
Strassel C; Eckly A; Léon C; Petitjean C; Freund M; Cazenave JP; Gachet C; Lanza F
Haematologica; 2009 Jun; 94(6):800-10. PubMed ID: 19377075
[TBL] [Abstract][Full Text] [Related]
4. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.
Ghevaert C; Salsmann A; Watkins NA; Schaffner-Reckinger E; Rankin A; Garner SF; Stephens J; Smith GA; Debili N; Vainchenker W; de Groot PG; Huntington JA; Laffan M; Kieffer N; Ouwehand WH
Blood; 2008 Apr; 111(7):3407-14. PubMed ID: 18065693
[TBL] [Abstract][Full Text] [Related]
5. Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano.
Balduini A; Malara A; Pecci A; Badalucco S; Bozzi V; Pallotta I; Noris P; Torti M; Balduini CL
J Thromb Haemost; 2009 Mar; 7(3):478-84. PubMed ID: 19067792
[TBL] [Abstract][Full Text] [Related]
6. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
[TBL] [Abstract][Full Text] [Related]
7. Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes.
Bury L; Malara A; Gresele P; Balduini A
PLoS One; 2012; 7(4):e34449. PubMed ID: 22539947
[TBL] [Abstract][Full Text] [Related]
8. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
9. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice.
Eckly A; Rinckel JY; Laeuffer P; Cazenave JP; Lanza F; Gachet C; Léon C
J Thromb Haemost; 2010 Oct; 8(10):2243-51. PubMed ID: 20695978
[TBL] [Abstract][Full Text] [Related]
10. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.
Roberts W; Michno A; Aburima A; Naseem KM
J Thromb Haemost; 2009 Dec; 7(12):2106-15. PubMed ID: 19765213
[TBL] [Abstract][Full Text] [Related]
12. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3.
Larson MK; Watson SP
Blood; 2006 Sep; 108(5):1509-14. PubMed ID: 16670270
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI.
Andrews RK; Gardiner EE; Shen Y; Berndt MC
Curr Med Chem Cardiovasc Hematol Agents; 2003 Jun; 1(2):143-9. PubMed ID: 15320694
[TBL] [Abstract][Full Text] [Related]
14. Endocytosed factor V is trafficked to CD42b
Gertz JM; McLean KC; Bouchard BA
J Cell Physiol; 2018 Nov; 233(11):8691-8700. PubMed ID: 29761851
[TBL] [Abstract][Full Text] [Related]
15. Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.
Avanzi MP; Izak M; Oluwadara OE; Mitchell WB
PLoS One; 2015; 10(4):e0125057. PubMed ID: 25875470
[TBL] [Abstract][Full Text] [Related]
16. [Chronic peripheral arterial occlusive disease, platelet glycoproteins GPIIb-IIIa and GP Ib-IX, plasma von Willebrand factor and plasma fibrinogen concentrations in patients with type 2 diabetes mellitus].
Gosk-Bierska I; Adamiec R; Doskocz W; Ciosek W
Pol Arch Med Wewn; 2000; 103(3-4):139-45. PubMed ID: 11236240
[TBL] [Abstract][Full Text] [Related]
17. The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition.
Chen Y; Boukour S; Milloud R; Favier R; Saposnik B; Schlegel N; Nurden A; Raslova H; Vainchenker W; Balland M; Nurden P; Debili N
J Thromb Haemost; 2013 Dec; 11(12):2163-75. PubMed ID: 24165359
[TBL] [Abstract][Full Text] [Related]
18. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.
Italiano JE; Lecine P; Shivdasani RA; Hartwig JH
J Cell Biol; 1999 Dec; 147(6):1299-312. PubMed ID: 10601342
[TBL] [Abstract][Full Text] [Related]
19. Terminal platelet production is regulated by von Willebrand factor.
Poirault-Chassac S; Nguyen KA; Pietrzyk A; Casari C; Veyradier A; Denis CV; Baruch D
PLoS One; 2013; 8(5):e63810. PubMed ID: 23737952
[TBL] [Abstract][Full Text] [Related]
20. Platelet physiology and thrombosis.
Andrews RK; Berndt MC
Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
